These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 10239345)
21. Regulating manufacturer-affiliated communication in the information age. Schulman KA; Abernethy DR; Rathore SS; Woosley RL Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664 [No Abstract] [Full Text] [Related]
22. Official written patient drug-use information. Heller WM Drug Inf J; 1978; 12(1):59-62. PubMed ID: 10308109 [No Abstract] [Full Text] [Related]
23. The Minnesota Medical Information Service. Schroeder RD Drug Inf J; 1975; 9(2-3):76-9. PubMed ID: 10236981 [No Abstract] [Full Text] [Related]
24. Black box warnings in prescription drug labeling: results of a survey of 206 drugs. Beach JE; Faich GA; Bormel FG; Sasinowski FJ Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718 [No Abstract] [Full Text] [Related]
25. Drug warnings and pharmacists' liability. Mazzucca GA Am J Pharm Sci Support Public Health; 1978; 150(6):199-201. PubMed ID: 727232 [No Abstract] [Full Text] [Related]
26. Internet pharmacies: opportunities and challenges. Navarro RP Manag Care Interface; 1999 Jun; 12(6):64, 66-7. PubMed ID: 10538462 [No Abstract] [Full Text] [Related]
27. Newly approved treatment INDs. Young FE Am Pharm; 1989 May; NS29(5):29-30. PubMed ID: 2729090 [No Abstract] [Full Text] [Related]
28. Compliance with Washington state's professional practice regulations: 1974 vs. 1987. Campbell RK; Baker DE; Jinks MJ; Evenson-St Amand LM Am Pharm; 1989 May; NS29(5):42-8. PubMed ID: 2729093 [No Abstract] [Full Text] [Related]
29. The patient information and education initiative. Rheinstein PH; McGinnis TJ; Nightingale SL Am Fam Physician; 1995 Dec; 52(8):2377-8, 2381-2. PubMed ID: 7484726 [No Abstract] [Full Text] [Related]
30. Drug information resources for treatment of acute drug overdose. Comstock EG Drug Inf J; 1975; 9(2-3):81-8. PubMed ID: 10236983 [No Abstract] [Full Text] [Related]
31. The medicolegal significance of the package insert. Hirsh HL Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155 [No Abstract] [Full Text] [Related]
32. Useful sources of foreign drug information. Ellis JM Drug Inf J; 1975; 9(2-3):110-3. PubMed ID: 10236962 [No Abstract] [Full Text] [Related]
34. VADICS--a drug therapy advisory system for physicians, pharmacists, and other health professionals. Salter FJ Drug Inf J; 1975; 9(2-3):114-9. PubMed ID: 10236963 [No Abstract] [Full Text] [Related]
35. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium. Garbutt BJ; Hofmann ME Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558 [No Abstract] [Full Text] [Related]
37. Online pharmaceutical regulation: an avenue to a safer world. Ward JM J Leg Med; 2003 Mar; 24(1):77-107. PubMed ID: 12623697 [No Abstract] [Full Text] [Related]
38. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs. Patsner B Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473 [No Abstract] [Full Text] [Related]
39. Information on marketed drugs for doctors and patients. Experience in six European countries. Brown P; Charlish P; Brazier H; Butterfield M Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543 [TBL] [Abstract][Full Text] [Related]